BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31789129)

  • 1. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.
    Wang Z; Li TE; Chen M; Pan JJ; Shen KW
    Aging (Albany NY); 2020 Jan; 12(2):1867-1887. PubMed ID: 31986487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
    Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
    J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
    Zhou Y; Wang M; Tong Y; Liu X; Zhang L; Dong D; Shao J; Zhou Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819875168. PubMed ID: 31506061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
    Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
    Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3.
    Zhang H; Wang M; Lang Z; Liu H; Liu J; Ma L
    Clinics (Sao Paulo); 2022; 77():100115. PubMed ID: 36228497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
    Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
    Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
    Li Y; Wang Y; Fan H; Zhang Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
    Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
    Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc Finger Protein 521, Negatively Regulated by MicroRNA-204-5p, Promotes Proliferation, Motility and Invasion of Gastric Cancer Cells.
    Huan C; Xiaoxu C; Xifang R
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874783. PubMed ID: 31526099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.
    Liu K; Xie F; Gao A; Zhang R; Zhang L; Xiao Z; Hu Q; Huang W; Huang Q; Lin B; Zhu J; Wang H; Que J; Lan X
    Mol Cancer; 2017 Mar; 16(1):62. PubMed ID: 28288641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.